secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001801170-24-000152
Event type: litigation
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Court approves settlement of Clover Health derivative suits, dismisses cases with prejudice
--------------------------------------------------------------------------------

- Court approved settlement of four consolidated shareholder derivative actions against Clover and its directors.
- Settlement provides for dismissal with prejudice, release of claims, and no admission of liability.
- Court awarded $2.5M in plaintiffs' counsel fees and expenses, plus $3,000 service awards to seven plaintiffs.
- Final judgment entered July 16, 2024; derivatives cases included in Tennessee, Delaware, and New York.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000152/0001801170-24-000152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000152/clov-20240716.htm
  HTML page:      https://secwatch.observer/filing/0001801170-24-000152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer